CVS HEALTH CORPORATION Foreign Income Tax Expense (Benefit), Continuing Operations
CVS HEALTH CORPORATION (CVS) reported Foreign Income Tax Expense (Benefit), Continuing Operations of $114.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:ForeignIncomeTaxExpenseBenefitContinuingOperations · last filed 2026-02-10
- CVS HEALTH CORPORATION foreign income tax expense (benefit), continuing operations for fiscal 2025 was $114.00M, a 192.31% increase from fiscal 2024.
- CVS HEALTH CORPORATION foreign income tax expense (benefit), continuing operations for fiscal 2024 was $39.00M, a 254.55% increase from fiscal 2023.
- CVS HEALTH CORPORATION foreign income tax expense (benefit), continuing operations for fiscal 2023 was $11.00M.
| Period end | Foreign Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2025-12-31 | $114.00M 10-K · filed 2026-02-10 |
| 2024-12-31 | $39.00M 10-K · filed 2026-02-10 |
| 2023-12-31 | $11.00M 10-K · filed 2026-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |